# API 并排问答 — 同一问题 × 8 检索算法

## sf-001 — 0-dimensional biomaterials lack inductive properties.

金标: 31715818

中间 Agent 排名: itrg_refresh(10.0) > deepread(9.0) > search_o1(9.0) > dense_rag(7.0) > itrg_refine(7.0) > dense_rag_rerank(7.0) > raptor(7.0) > qdcvr(6.0)

### qdcvr

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=2
- 回答(insufficient): Neither retrieved excerpt addresses biomaterials or their inductive properties: the first concerns mortality trends amenable to medical care in eastern Europe, and the second concerns meiotic recombination hotspots in the mouse MHC Ebeta gene. With no evidence on 0-dimensional biomaterials or inductive capacity, the claim cannot be supported or refuted from the supplied corpus.

### dense_rag

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The retrieved excerpts concern nitric oxide synthase/ peroxynitrite cytotoxicity, mGluR6 knockout visual transmission, and small-molecule enhancement of induced pluripotent stem cell reprogramming. None addresses biomaterial dimensionality (0-dimensional vs. other) or the inductive properties of biomaterials, so the claim cannot be evaluated from this evidence.

### dense_rag_rerank

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=8
- 回答(insufficient): None of the three retrieved excerpts address 0-dimensional biomaterials or their inductive properties. The evidence concerns embryonic BMP/ADMP morphogenetic self-regulation, small-molecule enhancement of iPSC reprogramming, and Myc-driven protein synthesis in cancer, none of which bear on the dimensionality of biomaterials. The claim therefore cannot be assessed from the provided corpus.

### raptor

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.000 judge=7
- 回答(insufficient): The claim concerns the inductive properties of 0-dimensional biomaterials, but none of the three retrieved excerpts address biomaterials, dimensionality, or tissue-inductive behavior. The passages cover peroxynitrite-mediated cytotoxicity in L-Arg-depleted cells, loss of ON visual responses in mGluR6 knockout mice, and small-molecule enhancement of iPSC reprogramming, none of which bear on the claim. No evidence in the corpus is relevant, so the claim can be neither supported nor refuted.

### itrg_refresh

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): None of the three retrieved excerpts addresses dimensionality of biomaterials or inductive properties. They concern nanotechnology for stem cell tracking/differentiation, prostaglandin E2 regulation of bone homeostasis, and outer membrane biogenesis in E. coli, so the claim cannot be evaluated from this evidence.

### itrg_refine

- 指标: hit@1=0.000 R@5=0.000 nDCG@10=0.333 judge=7
- 回答(insufficient): The retrieved excerpts concern nitric oxide synthase/ peroxynitrite cytotoxicity, mGluR6 knockout visual transmission, and small-molecule enhancement of induced pluripotent stem cell reprogramming. None addresses biomaterial dimensionality (0-dimensional vs. other) or the inductive properties of biomaterials, so the claim cannot be evaluated from this evidence.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Neither retrieved excerpt addresses 0-dimensional biomaterials or their inductive properties. Source 31715818 reviews nanotechnology platforms for stem cell labeling, delivery, and scaffold-based differentiation, and source 21676556 concerns midbody accumulation in stem cells; both relate to stem cell manipulation but neither defines dimensionality of biomaterials nor evaluates induction (e.g., osteogenic/chondrogenic differentiation) capability. The claim is therefore neither supported nor refuted by the provided evidence.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.500 judge=9
- 回答(insufficient): None of the three retrieved excerpts address 0-dimensional biomaterials or their inductive properties. The passages concern optogenetic trafficking strategies [8386609], replacement of OCT4/SOX2 in human cell reprogramming [16287725], and nanotechnology applications for stem cell tracking, differentiation, and transplantation [31715818]. Although [31715818] mentions engineered nanometer-scale scaffolds, it does not classify dimensionality nor assess inductive capability, so the claim cannot be evaluated from this evidence.

## sf-002 — 4-PBA treatment decreases endoplasmic reticulum stress in response to general endoplasmic reticulum stress markers.

金标: 32587939

中间 Agent 排名: qdcvr(10.0) > dense_rag_rerank(9.0) > deepread(9.0) > itrg_refine(8.0) > itrg_refresh(8.0) > raptor(8.0) > dense_rag(7.0) > search_o1(7.0)

### qdcvr

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): The two provided excerpts discuss ER stress biology (WFS1/AC8 complex formation and VAP-dependent endosome-ER contacts) but neither mentions 4-PBA (4-phenylbutyrate) treatment nor reports effects on general ER stress markers. No data on 4-PBA administration or marker changes (e.g., CHOP, BiP/GRP78, ATF4, XBP1) is present, so the claim cannot be evaluated from this evidence.

### dense_rag

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (sodium phenylbutyrate) or any chaperone/chemical treatment, and none measure general ER stress markers under such treatment; they concern VAP-dependent endosome-ER PI4P regulation, WFS1/AC8 ER stress signaling in beta cells, and G-quadruplex compounds in HR-deficient cells. The claim about 4-PBA decreasing ER stress is therefore not evaluable from the provided evidence.

### dense_rag_rerank

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=7
- 回答(insufficient): None of the retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment intervention; they describe WFS1/AC8 regulation of insulin secretion under ER stress and VAP-dependent endosome-ER contacts. The excerpts also report no general ER stress marker measurements (e.g., BiP/GRP78, CHOP, ATF4, XBP1) with or without treatment. Therefore the claim cannot be evaluated from the provided evidence.

### raptor

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### itrg_refresh

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=8
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### itrg_refine

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the three retrieved excerpts mention 4-PBA (4-phenylbutyric acid) or any treatment with it, nor do they report measurements of general ER stress markers before and after such treatment. The excerpts concern ER-endosome contact/PI4P regulation (600437), WFS1-AC8 interactions under ER stress (32587939), and G-quadruplex compounds in BRCA-deficient cells (16472469), none of which provide evidence for or against the claim.

### search_o1

- 指标: hit@1=1.000 R@5=1.000 nDCG@10=1.000 judge=9
- 回答(insufficient): Neither retrieved excerpt evaluates 4-PBA (4-phenylbutyric acid) or reports any general ER stress marker measurements following its treatment. Source [32587939] concerns WFS1/AC8 complex formation and insulin secretion during ER stress, and source [4961038] concerns PI3K/MEK inhibitors in K-Ras and PIK3CA mutant lung cancers; neither mentions 4-PBA or ER stress marker quantification. Therefore the claim cannot be assessed from the provided evidence.

### deepread

- 指标: hit@1=0.000 R@5=1.000 nDCG@10=0.631 judge=9
- 回答(insufficient): None of the provided excerpts mention 4-PBA (4-phenylbutyrate) or any treatment reducing endoplasmic reticulum stress markers. Sources [32587939] and the others discuss ER stress mechanisms (WFS1/AC8 in β-cells) and unrelated topics (G-quadruplex replication, bacterial two-component signaling), but contain no data on 4-PBA treatment or its effect on general ER stress markers. The claim therefore cannot be evaluated from this evidence.
